U.S. EDITION
Home
Thursday, December 19, 2013 As of 11:47 AM EST
World
U.S.
Business
Tech
Markets
Market Data
Your Money
Opinion
Life & Culture
N.Y.
Real Estate
Management
The Wall Street Journal news department was not involved in the creation of this content.
December 19, 2013, 11:47 a.m. ET
PRESS RELEASE
New Study Says Just 5% of Mental Health Patients Receive
Objective Test Before Getting Prescription Drugs
News, Quotes, Companies, Videos
Email
U.S. EDITION
Home
Printer
Friendly
Share:
facebook
SEARCH
Text
George's Journal
Thursday, December 19, 2013 As of 11:47 AM EST
World
U.S.
Business
Tech
Markets
Market Data
Your Money
Opinion
Life & Culture
N.Y.
Real Estate
Management
The Wall Street Journal news department was not involved in the creation of this content.
PRESS
RELEASE
New Study
Says
19, 2013,Health
11:47 a.m.
ET
JustDecember
5% of Mental
Patients
Receive Objective Test Before Getting Prescription Drugs
New
Study
Says
Just
5%
of Mental Health Patients Receive
96% of Patients
Expect Doctor
to Have
Objective
Information
Objective
Test Before Getting Prescription Drugs
CNS Response, Inc. Releases DCA Study
Email
Printer
Share:
facebook
Text
ALISO VIEJO,Friendly
Calif., Dec. 19, 2013 (GLOBE NEWSWIRE) -- CNS Response, Inc. (OTCQB:CNSO) announced today that Decision Calculus
Associates has released a new study today showing that just 5% of patients treated for depression with medication receive an objective test
prior to receiving a prescription. The study also showed that 96% of patients expect their physician to do an objective physical test before
prescribing psychotropic medications such as antidepressants.
"The dominant method of treatment today is trial & error, that's one of the reasons Psychiatric treatments fail more than they succeed," said
George Carpenter, CEO of CNS Response. "Doctors use objective information about how your brain might respond to different medications
New Study
Just
5% of Mental
Health
Patients
Receivefor
Objective
Test Before Getting Prescription Drugs
because
it's Says
better
medicine,
and their
patients
are asking
it."
96% of Patients
Expect Doctor
to Have
Information
Overall,
80% of patients
felt their
doctorObjective
used "trial
and error" prescribing. This number went up to 91% when three or more medications were
tried before finding one that worked.
CNS Response, Inc. Releases DCA Study
The results are from an anonymous online survey of 80 respondents fielded by Decision Calculus Associates. More in depth survey results,
ALISO VIEJO, Calif., Dec. 19, 2013 (GLOBE NEWSWIRE) -- CNS Response, Inc. (OTCQB:CNSO) announced today that Decision Calculus
methodology and questionnaire are available at: http://www.cnsresponse.com/topline-patients-want-more-information.html
Associates has released a new study today showing that just 5% of patients treated for depression with medication receive an objective test
prior to receiving
a prescription.
The study
also showed
that
of patients
physician
to do has
an objective
physical
beforepatient
Consumers
want objective
information
to guide
the choice
of96%
treatment.
Thisexpect
surveytheir
suggests
Psychiatry
an opportunity
totest
improve
prescribing
psychotropic
medications
such
as
antidepressants.
doctor relationships with more information.
"TheResponse
dominant(CNS)
method
treatment
todaysupport
is trial &company
error, that's
of the reasons
Psychiatric
treatments
fail more
than
they succeed,"
CNS
is aofclinical
decision
withone
a patented
commercial
neurometric
platform,
PEER
Online,
to predictsaid
drug
George
Carpenter,
CEO
of
CNS
Response.
"Doctors
use
objective
information
about
how
your
brain
might
respond
to
different
medications
response for treatment of brain disorders, including depression, anxiety, bipolar disorder and post-traumatic stress disorder. Using
PEER
because it's better
their patients
aresubject
asking trial
for it."
Technology,
CNS ismedicine,
currentlyand
performing
a 2,000
at Walter Reed National Military Medical Center focusing on depression, post-
traumatic stress disorder ("PTSD") and mild traumatic brain injury ("mTBI"). The trial currently has 51 sub-investigators and is active at
Overall, 80% of patients felt their doctor used "trial and error" prescribing. This number went up to 91% when three or more medications were
Walter Reed National Military Medical Center and Fort Belvoir Community Hospital.
tried before finding one that worked.
About CNS Response
The results are from an anonymous online survey of 80 respondents fielded by Decision Calculus Associates. More in depth survey results,
methodology
questionnaire
are
available
at: http://www.cnsresponse.com/topline-patients-want-more-information.html
CNS
Responseand
provides
reference
data
and analytic
tools for clinicians and researchers in psychiatry. Treatment for mental disorders has
doubled in the last 20 years, and use of medications has grown over 400% -- but treatments fail more often than they succeed and over 17
Consumers want objective information to guide the choice of treatment. This survey suggests Psychiatry has an opportunity to improve patient
million Americans have failed two or more medication therapies for their mental disorder. The company's Psychiatric EEG Evaluation
doctor relationships with more information.
Registry, or PEER Online, is a registry and reporting platform that allows medical professionals to exchange treatment outcome data for
patients
referenced
to is
objective
neurophysiology
data
obtained
through
a standard
electroencephalogram
(EEG).
Based
on thetocompany's
CNS Response
(CNS)
a clinical
decision support
company
with
a patented
commercial
neurometric platform,
PEER
Online,
predict drug
original
database,
there
are nowdepression,
more than anxiety,
36,000 outcomes
for 9,500
patients in
the PEER
registry.
responsephysician-developed
for treatment of brain
disorders,
including
bipolar disorder
andunique
post-traumatic
stress
disorder.
UsingThe
PEER
objective
of PEER
Online
is toperforming
avoid trial and
errorsubject
pharmacotherapy,
the
dominant
approach
treatment
resistant
patients.
Technology,
CNS is
currently
a 2,000
trial at Walter
Reed
National
Militaryfor
Medical
Center
focusing
on depression, posttraumatic stress disorder ("PTSD") and mild traumatic brain injury ("mTBI"). The trial currently has 51 sub-investigators and is active at
To discover more about the benefits of this patented technology for patients, physicians and payers, please visit www.cnsresponse.com.
Walter Reed National Military Medical Center and Fort Belvoir Community Hospital.
Medical professionals interested in learning more can contact CNS Response at [email protected].
About CNS Response
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
CNS Response provides reference data and analytic tools for clinicians and researchers in psychiatry. Treatment for mental disorders has
Except for the historical information contained herein, the matters discussed are forward-looking statements made pursuant to the safe
doubled in the last 20 years, and use of medications has grown over 400% -- but treatments fail more often than they succeed and over 17
harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements involve risks and
million Americans have failed two or more medication therapies for their mental disorder. The company's Psychiatric EEG Evaluation
uncertainties as set forth in the Company's filings with the Securities and Exchange Commission. These risks and uncertainties could cause
Registry, or PEER Online, is a registry and reporting platform that allows medical professionals to exchange treatment outcome data for
actual results to differ materially from any forward-looking statements made herein.
patients referenced to objective neurophysiology data obtained through a standard electroencephalogram (EEG). Based on the company's
CONTACT: Investor Relations:
Marty Tullio, Managing Partner
McCloud Communications, LLC
949.632.1900